NL101 synergizes with the BCL-2 inhibitor venetoclax through PI3K-dependent suppression of c-Myc in acute myeloid leukaemia. - Lu, Ying; Jiang, Xia; Li, Youhong; Li, Fenglin; Zhao, Mengting; Lin, Ye; Jin, Lili; Zhuang, Haihui; Li, Shuangyue; Ye, Peipei; Pei, Renzhi; Jin, Jie; et al. (Journal of Translational Medicine, 2024)